Marita Kailajärvi

PET amyloid ligand [ ¹¹ C]PIB uptake is increased in mild cognitive impairment

Nina Kemppainen, Sargo Aalto, Ian A. Wilson et al. · Neurology · 2007 · 309 citations

Medicine, Neuroscience, Nuclear Medicine +17

Voxel-based analysis of PET amyloid ligand [ ¹¹ C]PIB uptake in Alzheimer disease

Nina Kemppainen, Sargo Aalto, Ian A. Wilson et al. · Neurology · 2006 · 223 citations

Medicine, Neurology, Neuroscience +17

Comparison of pharmacokinetic profile of levodopa throughout the day between levodopa/carbidopa/entacapone and levodopa/carbidopa when administered four or five times daily

Mikko Kuoppamäki, Kirsi Korpela, Reijo J. Marttila et al. · European Journal of Clinical Pharmacology · 2009 · 83 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +12

[18F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies

Juha O. Rinne, Dean F. Wong, David A. Wolk et al. · Acta Neuropathologica · 2012 · 82 citations

Medicine, Neurology, Neuroscience +14

Assessment of MAO-B Occupancy in the Brain With PET and [11C]-L-Deprenyl-D2: A Dose-Finding Study With a Novel MAO-B Inhibitor, EVT 301

Jussi Hirvonen, Marita Kailajärvi, Tuomas Haltia et al. · Clinical Pharmacology & Therapeutics · 2009 · 65 citations

Medicine, Neuroscience, Pharmacology +15